The National Cancer Institute is currently exploring the potential of ivermectin as a treatment for cancer, as stated by the institute’s director, Anthony Letai. Letai mentioned that there have been enough reports and interest in the use of ivermectin for this purpose to warrant a more thorough preclinical study to determine its effectiveness in killing cancer cells. The drug, commonly used as an antiparasitic medication for humans and animals, has gained popularity as a dewormer for horses.
The decision to investigate ivermectin as a cancer treatment has raised concerns among some career scientists at the National Cancer Institute. They question the allocation of funds for this study, considering the lack of concrete evidence supporting its efficacy in treating cancer. Despite the FDA’s approval of ivermectin for specific uses, such as treating parasitic infections, there are risks associated with large doses of the drug, including seizures, comas, or even death.
While previous laboratory research has suggested that ivermectin could have anticancer properties by promoting cell death and inhibiting tumor growth, there is still no conclusive evidence that it is safe and effective in treating cancer in humans. Some physicians worry that patients may delay or forego proven cancer treatments in favor of unfounded claims about ivermectin’s effectiveness.
Celebrities and online influencers have perpetuated the idea that ivermectin is a miracle cure for various diseases, including cancer, despite the lack of scientific backing. This misinformation has led to lawmakers in certain states making the drug available over the counter and funding research to study its potential as a cancer treatment.
Director Letai emphasized that while the NIH is open to exploring new ideas, including the use of off-label drugs like ivermectin, rigorous scientific methods must be applied to evaluate their efficacy. He also cautioned against viewing ivermectin as a universal cure for cancer, stating that it may not be effective on a population level.
In conclusion, the National Cancer Institute’s investigation into ivermectin as a potential cancer treatment has sparked debate within the scientific community. While the drug shows promise in preclinical studies, more research is needed to determine its safety and efficacy in treating cancer in humans. It is essential for patients to consult with healthcare professionals and rely on evidence-based treatments for their medical conditions.
